Intermittent Dosing | List of Frontiers open access articles

Original Research

Published on 05 Jun 2025

Real-world treatment persistence and predictive factors for discontinuation of antifibrotic therapies in patients with idiopathic pulmonary fibrosis: a post-hoc analysis of two multicenter observational cohort studies in Poland

in Respiratory Pharmacology

Sebastian Majewski
Katarzyna Górska
Katarzyna B. Lewandowska
Magdalena M. Martusewicz-Boros
Małgorzata Sobiecka
Wojciech J. Piotrowski

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1586197

3,751 views
1 citation

Original Research

Published on 29 Sep 2022

Intermittent MEK inhibition for the treatment of metastatic uveal melanoma

in Skin Cancer

Shaheer Khan
Sapna P. Patel
Alexander N. Shoushtari
Grazia Ambrosini
Serge Cremers
Shing Lee
Lauren Franks
Shahnaz Singh-Kandah
Susana Hernandez
Naomi Sender

Frontiers in Oncology

doi 10.3389/fonc.2022.975643

6,164 views
8 citations

Original Research

Published on 02 Aug 2021

Efficacy of a Novel Bi-Steric mTORC1 Inhibitor in Models of B-Cell Acute Lymphoblastic Leukemia

in Hematologic Malignancies

Bianca J. Lee
Sharmila Mallya
Nuntana Dinglasan
Amos Fung
Tram Nguyen
Lee-or Herzog
Joshua Thao
Edward G. Lorenzana
David Wildes
Mallika Singh

Frontiers in Oncology

doi 10.3389/fonc.2021.673213

5,209 views
15 citations

Original Research

Published on 18 May 2018

Pharmacokinetics and Pharmacodynamics of Tildipirosin Against Pasteurella multocida in a Murine Lung Infection Model

in Antimicrobials, Resistance and Chemotherapy

Dongping Zeng
Meizhen Sun
Zhoumeng Lin
Miao Li
Ronette Gehring
Zhenling Zeng

Frontiers in Microbiology

doi 10.3389/fmicb.2018.01038

7,361 views
30 citations

Original Research

Published on 05 Jan 2026

Preclinical pharmacological profiles of cofrogliptin, a novel and bi-weekly DPP-4 inhibitor

in Experimental Pharmacology and Drug Discovery

Xiaoli Gou
Caixia Dou
Pingming Tang
Xiaoxiao Zheng
Chen Zhang
Jianmin Wang
Qingyuan Meng
Ju Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1702101

906 views

Original Research

Published on 19 Mar 2019

Preclinical Evaluation of Bispecific Adaptor Molecule Controlled Folate Receptor CAR-T Cell Therapy With Special Focus on Pediatric Malignancies

in Pediatric Oncology

Yingjuan J. Lu
Haiyan Chu
Leroy W. Wheeler
Melissa Nelson
Elaine Westrick
James F. Matthaei
Ian I. Cardle
Adam Johnson
Joshua Gustafson
Nikki Parker

Frontiers in Oncology

doi 10.3389/fonc.2019.00151

14,867 views
61 citations

Study Protocol

Published on 07 Aug 2025

Continuous infusion versus intermittent dosing of ceftazidime/avibactam in critically ill patients with Klebsiella pneumoniae OXA-48 or Pseudomonas aeruginosa infections: a single-center randomized open-label trial (ZAVICONT). Rationale and design

in Pharmacology of Infectious Diseases

Mirna Momčilović
Ivan Šitum
Ante Erceg
Marko Siroglavić
Mila Lovrić
Laura Nižić Nodilo
Anita Hafner
Jasmina Lovrić
Petra Turčić
Dora Fabijanović

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1618987

2,808 views

Original Research

Published on 26 Mar 2024

Lung microdialysis and in vivo PK/PD integration of cefquinome against Actinobacillus pleuropneumoniae in a porcine experimental lung infection model

in Veterinary Pharmacology and Toxicology

Yuqin Chen
Min Li
Dehai Su
Shiyu Xiong
Youshu Feng
Qin Deng
Huanzhong Ding

Frontiers in Veterinary Science

doi 10.3389/fvets.2024.1390336

2,120 views

Articles

Real-world treatment persistence and predictive factors for discontinuation of antifibrotic therapies in patients with idiopathic pulmonary fibrosis: a post-hoc analysis of two multicenter observational cohort studies in Poland

Intermittent MEK inhibition for the treatment of metastatic uveal melanoma

Efficacy of a Novel Bi-Steric mTORC1 Inhibitor in Models of B-Cell Acute Lymphoblastic Leukemia

Pharmacokinetics and Pharmacodynamics of Tildipirosin Against Pasteurella multocida in a Murine Lung Infection Model

Preclinical pharmacological profiles of cofrogliptin, a novel and bi-weekly DPP-4 inhibitor

Preclinical Evaluation of Bispecific Adaptor Molecule Controlled Folate Receptor CAR-T Cell Therapy With Special Focus on Pediatric Malignancies

Continuous infusion versus intermittent dosing of ceftazidime/avibactam in critically ill patients with Klebsiella pneumoniae OXA-48 or Pseudomonas aeruginosa infections: a single-center randomized open-label trial (ZAVICONT). Rationale and design

Lung microdialysis and in vivo PK/PD integration of cefquinome against Actinobacillus pleuropneumoniae in a porcine experimental lung infection model